Avita Medical | 1811094D - 净收入



金融业
股票价格
AUD
资产
AUD 56.39M
现金及等价物
AUD 10.24M
销售成本
AUD 3.3M
流动资产
AUD 35.49M
流动负债
AUD 62.68M
债务
AUD 46.05M
EBIT
AUD -10.39M
EBITDA
AUD -9.69M
员工
AUD 87
EPS每股收益
AUD -0.38
股本和储备
AUD -16.65M
销售毛利
AUD 14.31M
债务利息支出
AUD 1.25M
贷款资金
AUD 42.25M
市值
AUD 383.18M
净收入
AUD -11.62M
营业费用
AUD 28.02M
营业利润
AUD -10.41M
税前利润
AUD -11.64M
销售收入
AUD 17.62M
销售和管理费用
AUD 19.03M
股票
AUD 6.93M
贸易债权人
AUD 8.96M
应收帐款人
AUD 9.11M


净收入 更改 日
Accuray USD 2.54M 6.49M 2024-12
Celltrion KRW 8.82B 64.74M 2026-03
Clinuvel Pharmaceuticals AUD 10.44M 11.65M 2025-12
Cochlear AUD 161.5M 69.6M 2025-12
CSL USD 401M 96.5M 2025-12
Cspc Pharmaceutical CNY 370.72M 592.81M 2025-12
Deva Holding AS TRY 583.98M 319.1M 2023-09
Dianthus Therapeutics USD -40.83M 23.6M 2026-03
Divis Laboratories Ltd INR 9.02B 1.51B 2026-06
Kangmei Pharma CNY -16.56M 12.74M 2026-03
Knight Therapeutics CAD -3.79M 8.83M 2025-09
Laboratorios Farma EUR 103.69M 37.04M 2023-12
Malin Corporation EUR -1.1M 2.2M 2023-12
Mayne Pharma AUD -103.68M 68.4M 2024-06
Medical Developments International AUD -226K 121K 2025-12
Nanosonics AUD 9.64M 4.18M 2025-12
Neuren Pharmaceuticals AUD 15.4M 7.88M 2025-12
Organigram Holdings CAD -921K 20.89M 2026-03
Ovoca Bio EUR 4.42M 5.19M 2025-12
Pacific Edge NZD -16.66M 2.45M 2026-06
Paradigm Biopharmaceuticals AUD -23.24M 16.82M 2025-12
Pharma Mar EUR -972K 2.5M 2026-06
Polynovo AUD 3K 9.87M 2025-12
PYC Therapeutics AUD -22.83M 10.46M 2025-12
Qiagen NV USD 103.4M 35.36M 2026-06
Ramsay Health Care AUD 152.7M 32.4M 2025-12
ResMed USD 398.73M 6.14M 2026-03
Sartorius EUR 65.9M 9.7M 2026-06
Sino Biopharmaceutical CNY 3.39B 2.91B 2025-06
Telix Pharmaceuticals AUD 38.33M 43.16M 2026-06
Tilray USD -44.93M 44.61M 2025-09
Zealand Pharma A/S -394M 14.88M 2026-03
Zz Pientze Pharmaceu CNY 743.48M 56.45M 2026-03